AquaBounty Technologies, Inc.

NasdaqCM:AQB 株式レポート

時価総額：US$6.3m

AquaBounty Technologies 配当と自社株買い

配当金 基準チェック /06

AquaBounty Technologies配当金を支払った記録がありません。

主要情報

n/a

配当利回り

-15.3%

バイバック利回り

総株主利回り-15.3%
将来の配当利回りn/a
配当成長n/a
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
配当性向n/a

最近の配当と自社株買いの更新

更新なし

Recent updates

Seeking Alpha • Aug 20

AquaBounty: Not Casting A Lure Yet

This land-based salmon producer is a unique take on aquaculture, but risks abound. The current market cap does not take into consideration the low production plans, even with a new facility under construction. The looming clouds on the horizon means I will dock my boat for until things clear. A Pass On Land Based Fish Farms AquaBounty (AQB) is a company developing dry land farms to raise and sell salmon to the market to take demand away from wild caught salmon. The hot words to consider is that these salmon are both genetically engineered and farm raised. Public image issues aside, other risks that have plagued the company are due to the lack of FDA approval (of farm sites) and harvest issues. This has prevented this aging company from seeing any significant development since the early 90s. AquaBounty August Investor Presentation Advantages of the AquaBounty platform, or the trademark AquAdvantage Salmon, are many-fold. Initially, the major benefits revolve around faster growth, reproduction cycles, and ease of harvest, all allowing for a reduction in salmon cost. This either allows AquaBounty to sell at market price for a significant profit, or attempt to steal major market share by offering the lowest prices. Residual effects revolve around the issues inherent in wild-caught fish: ecological impacts, transportation impact, catch risks, food-borne illness, or biomagnification. The current issue is that AquaBounty is still working out the kinks and is yet to produce a full-scale operational facility. However, the bet is that once equilibrium is found, the platform, or these farms and salmon, can be developed worldwide, and the market share looks to be significant. In particular, it seems that commercial usage looks quite favorably upon the genetically engineered salmon, and in time, retail consumers may swing around as well. Investors should feel quite confident in the ability to find customers, but uncertainty around the funding of aquaculture centers and the improvement of harvest yields will be an issue for the coming years. Just look at the small amount of revenues that have been found since initiating the process nearly 30 years ago. Koyfin Revenues are derived from two initial farms in Indiana and Prince Edward Island, Canada. However, these sites will only have a maximum yield of approximately 1,000 metric tons per year. This contrasts significantly with the over 160 million tons of salmon processed per year, in the US. The table below is a great way to realize the sheer size of the fishery market, and to begin understanding the benefits of taking a dent out of the amount of fish we obtain from the oceans. Because of this, AquaBounty’s story will remain not one plagued by demand issues, but rather supply constraints. To combat the lack of supply from their two initial production experiment sites, the company has recently begun construction of a larger 10,000 metric ton facility that will easily provide over 5x current harvest yields. NOAA Fisheries 2020 Report The main problem, as usual, is money. While the company has done well to raise millions at the peak of the recent bull market, current estimates for the price of the new facility will drain the coffer. Now the company is not looking to dilute but to issue bonds instead, partially tempering the hit to current shareholders. However, no funding has come for six quarters and the cash on hand is slowly falling away. As of the August earnings press release, management had the following comments: On the bond financing front, we have decided to slow the process down temporarily in order to evaluate the current economic forces that are driving both inflation and interest rates higher. Since our estimate for construction of the farm currently exceeds our previous range of $290 - $320 million, we will review all options for reducing cost, including potentially phasing the construction of the 10,000 metric ton farm with an initial production output level that would demonstrate our competitive advantage and ability to operate at commercial scale. Koyfin AquaBounty The Future As only uncertainty exists and current supply is only worth a few million per year, I will certainly be remaining on the sideline. However, I look to the success of their construction and will be following their developments. If you are interested in this story, I will offer some valuation points to consider. Based on prices provided by the 2020 NOAA Fisheries report (see above), the value per pound for Salmon is approximately $5/lb at commercial scale.
Seeking Alpha • Aug 09

AquaBounty Technologies GAAP EPS of -$0.08, revenue of $1.07M

AquaBounty Technologies press release (NASDAQ:AQB): Q2 GAAP EPS of -$0.08. Revenue of $1.07M (+365.2% Y/Y).
Seeking Alpha • Mar 15

AquaBounty CEO Sylvia Wulf - Genetically Modified Sustainable Salmon

AquaBounty is an aquaculture company that bioengineered an FDA-approved genetically modified fish (AquAdvantage salmon) that grows faster and requires less food. CEO Sylvia Wulf on challenging GMO misinformation. AquaBounty’s financials and what investors can expect moving forward in terms of capital raises and shareholder dilution.
分析記事 • May 09

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Feb 10

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

Every investor in AquaBounty Technologies, Inc. ( NASDAQ:AQB ) should be aware of the most powerful shareholder groups...
分析記事 • Dec 20

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Even if it's not a huge purchase, we think it was good to see that Richard Huber, the Independent Non-Executive...

決済の安定と成長

配当データの取得

安定した配当: AQBの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: AQBの配当金が増加しているかどうかを判断するにはデータが不十分です。

配当利回り対市場

AquaBounty Technologies 配当利回り対市場
AQB 配当利回りは市場と比べてどうか？
セグメント配当利回り
会社 (AQB)n/a
市場下位25% (US)1.4%
市場トップ25% (US)4.1%
業界平均 (Biotechs)2.2%
アナリスト予想 (AQB) (最長3年)n/a

注目すべき配当: AQBは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: AQBは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。

株主への利益配当

収益カバレッジ: AQBの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。

株主配当金

キャッシュフローカバレッジ: AQBが配当金を報告していないため、配当金の持続可能性を計算できません。

高配当企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/09/13 05:31
終値2026/09/11 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

AquaBounty Technologies, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3

アナリスト機関
Frank BarlowKeefe, Bruyette, & Woods
Benjamin KlieveLake Street Capital Markets, LLC
Colin RuschOppenheimer & Co. Inc.